Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs) are the treatment of choice for several cancers and can be associated with remarkable clinical benefit, but can also cause serious immune-related adverse events (irAEs). Management of rare and severe irAEs is challenged by an incomplete knowledge of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Appelbaum, Jacob, Wells, David, Hiatt, Joseph B., Steinbach, Gideon, Stewart, F. Marc, Thomas, Hannah, Nghiem, Paul, Kapur, Raj P., Thompson, John A., Bhatia, Shailender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117974/
https://www.ncbi.nlm.nih.gov/pubmed/30170630
http://dx.doi.org/10.1186/s40425-018-0396-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117974/
https://www.ncbi.nlm.nih.gov/pubmed/30170630
http://dx.doi.org/10.1186/s40425-018-0396-9

Ejemplares similares